Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059)in the kindling model of temporal lobe epilepsy

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 2, 1998, Pages 474-479

  Löscher, Wolfgang ^a   Hönack, Dagmar ^a   Rundfeldt, Chris ^a,b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b Arzneimittelwerk   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DOSE RESPONSE; DRUG HALF LIFE; ELECTROSTIMULATION; FEMALE; GRAND MAL SEIZURE; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; PRIORITY JOURNAL; RAT; TEMPORAL LOBE EPILEPSY;

ANIMALS; ANTICONVULSANTS; BEHAVIOR, ANIMAL; EPILEPSY; FEMALE; KINDLING, NEUROLOGIC; PIRACETAM; RATS; RATS, WISTAR;

EID: 0031908063     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Albertson TE, Joy R and Stark LG (1984) Carbamazepine: a pharmacological study in the kindling model of epilepsy. Neuropharmacology 23:1117-1123.
2. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P and Perucca E (1996) Progress report on new antiepileptic drugs: a summary of the Third Eilat Conference. Epilepsia 25:299-319.
3. Chadwick D (1995) Is intractable epilepsy preventable? In Intractable Epilepsy, (Johannessen SI, Gram L, Sillanpää M and Tomson T eds) pp 255-260, Wrightson Biomedical Publishing, Petersfield.
4. Chadwick DW, Marson T and Kadir Z (1996) Clinical administration of new anti-epileptic drugs: An overview of safety and efficacy. Epilepsia 37(Suppl. 6):S17-S22, 1996.
5. Dunham NW and Miya TS (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 46:208-209.
6. Gower AJ, Noyer M, Verloes R, Gobert J and Wülfert E (1992) ucb L059, a novel anti-convulsant drug: pharmacological profile in animals. Eur J Pharmacol 222: 193-203.
7. Gower AJ, Hirsch E, Boehrer A, Noyer M and Marescaux C (1995) Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy. Epilepsy Res 22:207-213.
8. Hernandez TD (1997) Preventing post-traumatic epilepsy after brain injury: Weighing the costs and benefits of anticonvulsant prophylaxis. Trends Pharmacol Sci 18:59-62.
9. Hönack D and Löscher W (1995) Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia 36:763-771.
10. Klitgaard H, Matagne A, Gobert J and Wülfert E (1996) Levetiracetam (ucb L059) prevents limbic seizures induced by pilocarpine and kainic acid in rats. Epilepsia 37(Suppl. 5):118, 1996.
11. Löscher W, Hönack D and Bloms-Funke P (1996) The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata. Brain Res 735:208-216.
12. Löscher W and Hönack D (1993) Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol 232:147-158.
13. Löscher W and Schmidt D (1993) New drugs for the treatment of epilepsy. Curr Opin Invest Drugs 2:1067-1095.
14. Margineanu DG and Wülfert E (1995) ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal C. A.3 in vivo. Eur J Pharmacol 286:321-325.
15. Noyer M, Gillard M, Matagne A, Hénichart J-P and Wülfert E (1995) The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur J Pharmacol 286:137-146.
16. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
17. Racine RJ (1972) Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroenceph Clin Neurophysiol 32:281-294.
18. Sacaan AI and Lloyd GK (1994) The binding of the anticonvulsant levetiracetam to rat brain membranes distinguishes a novel site relevant to antiepileptic drug action. Neuropsychopharmacology 10:133S, 1994.
19. Sato M, Racine RJ and Mcintyre DC (1990) Kindling: Basic mechanisms and clinical validity. Electroenceph Clin Neurophysiol 76:459-472.
20. Scheuer ML and Pedley TA (1990) The evaluation and treatment of seizures. N Engl J Med 323:1468-1474.
21. Silver JM, Shin C and Mcnamara JO (1991) Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann Neurol 29:356-363.
22. Stables JP, Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P and Perucca E (1995) Progress report on new antiepileptic drugs a summary of the Second Eilat Conference. Epilepsy Res 22:235-246.
23. Verloes R, Scotto AM, Gobert J and Wülfert E (1988) Effects of nootropic drugs in a scopolamine-induced amnesia model in mice. Psychopharmacology 95:226-230.
24. Wada JA (1974) Pharmacological prophylaxis in the kindling model of epilepsy. Arch Neurol 34:389-395.